Your browser doesn't support javascript.
loading
Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study.
Al Sulaiman, Khalid; Aljuhani, Ohoud; Bin Salah, Khalid; Korayem, Ghazwa B; Eljaaly, Khalid; Al Essa, Mohammed; Kharbosh, Abdullah; Al Harbi, Feras; Abuzaid, Maram; Al Bilal, Sarah; Almagthali, Alaa; Alsohemi, Samia; Alshabasy, Adel; Noureldeen, Haytham; Aboudeif, Mohammed; Alshehri, Asma; Vishwakarma, Ramesh.
Afiliação
  • Al Sulaiman K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia
  • Aljuhani O; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Bin Salah K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia
  • Korayem GB; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Eljaaly K; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; College of Pharmacy, University of Arizona, Tucson, AZ, United States.
  • Al Essa M; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Kharbosh A; Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
  • Al Harbi F; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Abuzaid M; Department of Clinical Pharmacy, Prince Mohamed bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
  • Al Bilal S; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia.
  • Almagthali A; Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Alsohemi S; Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Alshabasy A; Department of Anesthesia and Intensive Care, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Anesthesia and Intensive care, Ain Shams University, Egypt.
  • Noureldeen H; Department of Anesthesia and Intensive Care, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Anesthesia and Intensive care, Ain Shams University, Egypt.
  • Aboudeif M; Department of Anesthesia and Intensive Care, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alshehri A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia.
  • Vishwakarma R; King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia.
J Crit Care ; 66: 44-51, 2021 12.
Article em En | MEDLINE | ID: mdl-34438133
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article